Clinical trial
Prospective Study on the Frequency of de Novo Atrial Fibrillation in Septic Shock in Medical Intensive Care
NCT02856191 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study on the Frequency of de Novo Atrial Fibrillation in Septic Shock in Medical Intensive Care
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- Not reported
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, septic shock